Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Karen Anne Cadoo"'
Publikováno v:
The Oncologist. 17:1135-1145
There is increased understanding of the heterogeneity of breast tumors, with greater emphasis now being placed on histological and molecular profiles and, in particular, their implications for prognosis and therapy. This review addresses breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::155e04e40970905729db4faf96eeb5f6
https://doi.org/10.1634/theoncologist.2012-0134
https://doi.org/10.1634/theoncologist.2012-0134
Autor:
Joanna Ti, Karen Anne Cadoo, Nessa O’Donnell, David A Allcutt, Michael A. Farrell, Liam Grogan, John Greene
Publikováno v:
Clinical Neuropathology. 32:139-141
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82263822403a2fb5d1b6a158b4b9083d
https://doi.org/10.5414/np300507
https://doi.org/10.5414/np300507
Autor:
Rachel N. Grisham, Dilip D. Giri, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Sean Patrick McGrath, Roisin Eilish O'Cearbhaill, Paul Sabbatini, William P. Tew, David Michael Hyman, Martee Leigh Hensley, Dmitriy Zamarin, Jason A. Konner, Alexandra Snyder Charen, Karen Anne Cadoo, David R. Spriggs, Gopa Iyer, Carol Aghajanian
Publikováno v:
Journal of Clinical Oncology. 35:TPS5610-TPS5610
TPS5610 Background: Approximately 75% of women with epithelial ovarian cancer (OC) present with advanced disease. Most of these women will ultimately recur and require life-long treatment for their cancer. Well tolerated therapies for treatment in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dbdce32dcd9fe6672b0b89ef153c2c0
https://doi.org/10.1200/jco.2017.35.15_suppl.tps5610
https://doi.org/10.1200/jco.2017.35.15_suppl.tps5610
Autor:
Megan Greally, William Grogan, Michelle O'Brien, Lynda M. O'Riordan, Oscar S. Breathnach, Niamh Coleman, Karen Anne Cadoo
Publikováno v:
Journal of Clinical Oncology. 31:e13019-e13019
e13019 Background: High grade gliomas(HGG) are aggressive primary brain tumors. Most patients relapse following adjuvant therapy and treatment options are limited. Novel therapies have impacted little on overall survival (OS). Bevacizumab is approved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03ab3cd418b65c85afd56df6472520a4
https://doi.org/10.1200/jco.2013.31.15_suppl.e13019
https://doi.org/10.1200/jco.2013.31.15_suppl.e13019
Autor:
Desmond N. Carney, Grainne M. O'Kane, Sean Dudney, Elaine M. Walsh, Conor O'Keane, Karen Anne Cadoo, Gary C. O’Toole
Publikováno v:
Journal of Clinical Oncology. 31:10530-10530
10530 Background: Chemotherapy in the treatment of osteosarcoma has improved 5 year overall survival (OS) from 20% with surgery alone to 60-70%. However, poor tumor necrosis following neoadjuvant chemotherapy (NAC) is associated with decreased surviv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bb1fd127398d635a730d47cca9ce253
https://doi.org/10.1200/jco.2013.31.15_suppl.10530
https://doi.org/10.1200/jco.2013.31.15_suppl.10530
Autor:
Donna M. Graham, Grzegorz Korpanty, Desmond N. Carney, D. G. Power, Karen Anne Cadoo, Grainne M. O'Kane, Elaine M. Walsh
Publikováno v:
Journal of Clinical Oncology. 31:e12533-e12533
e12533 Background: Cancer in pregnancy accounts for ~1 in 1,000 pregnancies. Studies show that cytotoxic agents are safe from the second trimester. Long-term follow up has not shown increased malformations or malignancies in children exposed to chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77f497c599374316a4ca4c4cf1830237
https://doi.org/10.1200/jco.2013.31.15_suppl.e12533
https://doi.org/10.1200/jco.2013.31.15_suppl.e12533
Autor:
T. Boyle, Elizabeth Connolly, Roisin Clarke, Patrick J. Morrison, Michael P. Farrell, Karen Anne Cadoo, Malcolm R. Kell, John McCaffrey, Michael A. Maher, Emmet Jordan, M. John Kennedy, David J. Gallagher, Cian Muldoon, Carmel Nolan
Publikováno v:
Journal of Clinical Oncology. 30:1543-1543
1543 Background: Breast cancer is not among the recognised malignant manifestations of Lynch Syndrome which include colorectal, endometrial, gastric, ovarian and upper urinary tract tumours. In this study we report the prevalence of breast cancer in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df62d4d2fc8ff2b537994f6d9a8ee9f1
https://doi.org/10.1200/jco.2012.30.15_suppl.1543
https://doi.org/10.1200/jco.2012.30.15_suppl.1543
Publikováno v:
Journal of Clinical Oncology. 27:e19516-e19516
e19516 Background: Anthracycline based chemotherapy is the treatment of choice for aggressive primary lymphomas of the GI tract, with surgery reserved for management of complications. We report long term follow up of 71 cases of primary GI NHL treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81a892b6f30b160e05c5b7f06b703796
https://doi.org/10.1200/jco.2009.27.15_suppl.e19516
https://doi.org/10.1200/jco.2009.27.15_suppl.e19516